Krisana PengsaaKriengsak LimkittikulArunee SabchareonChurdchoo AriyasriwatanaPornthep ChanthavanichPhanosri AttanathClaudius MalerczykMahidol UniversityQueen Sirikit National Institute of Child HealthNovartis Vaccines and Diagnostics2018-09-132018-09-132009-01-01Pediatric Infectious Disease Journal. Vol.28, No.4 (2009), 335-33715320987089136682-s2.0-65649111203https://repository.li.mahidol.ac.th/handle/20.500.14594/28271After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 years postvaccination. The inclusion of rabies vaccine in the expanded program on immunization should be considered in rabies endemic countries. Copyright © 2009 by Lippincott Williams & Wilkins.Mahidol UniversityMedicineA three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccineArticleSCOPUS10.1097/INF.0b013e3181906351